Quest Diagnostics (DGX) Tops Q4 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $250.81 -0.4%
Financial Fact:
Amortization of intangible assets: 18M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Amortization of intangible assets: 18M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.
GUIDANCE:
Quest Diagnostics sees FY2018 EPS of $6.50-$6.70, versus the consensus of $6.61.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- ONE Gas (OGS) Tops Q3 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Ero Copper Corp. (ERO) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
